Plato Investment Management Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1984475 SYDNEY, C3

Position in REGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,483,559

-$235,361 QoQ

Shares Held

3,983

+13.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#489

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Plato Investment Management Ltd holds $8,720,382 across 6 Biotechnology names. REGN ranks #2 (28.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,083	$3,021,608
2	REGN	Regeneron Pharmaceuticals, Inc. This page	3,983	$2,483,559
3	INCY	Incyte Corp	14,856	$1,684,076
4	ALNY	Alnylam Pharmaceuticals, Inc.	3,671	$1,105,081
5	EXEL	Exelixis, Inc.	5,702	$310,245
6	BMRN	Biomarin Pharmaceutical Inc	2,024	$115,813

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,483,559	3,983	+13.2%	Shares	Sole	2026-08-07
2026-03-31	$2,718,920	3,519	0.0%	Shares	Sole	2026-05-05
2025-12-31	$2,716,210	3,519	+0.9%	Shares	Sole	2026-02-04
2025-09-30	$1,960,073	3,486	-7.8%	Shares	Sole	2025-11-05
2025-06-30	$1,983,975	3,779	+0.1%	Shares	Sole	2025-08-05
2025-03-31	$2,395,486	3,777	+41.9%	Shares	Sole	2025-05-20
2024-12-31	$1,895,510	2,661	+1.7%	Shares	Sole	2025-02-06
2024-09-30	$2,751,095	2,617	+3.1%	Shares	Sole	2024-11-06
2024-06-30	$2,667,514	2,538	+6.0%	Shares	Sole	2024-08-09
2024-03-31	$2,304,201	2,394	+1846.3%	Shares	Sole	2024-05-17
2023-12-31	$108,029	123	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.